Search












The lists contain medicinal products or product categories subject to prescription which shall not bear the safety features (White list) and medicinal products or product categories not subject to prescription which shall bear the safety features (Black list)
Number of records: 206
Name of the medicinal product Supplement
SÚKL code Registration Number SPC ? PIL ? ATC group MA status ?
OCTOSTIM DOSIERSPRAY 1,5 MG/ML 1,5MG/ML NAS SPR SOL 1X2,5ML
0207603 octostimdo.pdf octostimdo.pdf H01BA02 F
OCTREOTIDE TEVA 10MG INJ PLQ SUS PRO 3+3X2ML ISP
0243404 56/ 467/17-C octreotide.pdf octreotide.pdf H01CB02 R
OCTREOTIDE TEVA 20MG INJ PLQ SUS PRO 3+3X2ML ISP
0243405 56/ 468/17-C octreotide.pdf octreotide.pdf H01CB02 R
OCTREOTIDE TEVA 30MG INJ PLQ SUS PRO 3+3X2ML ISP
0243406 56/ 469/17-C octreotide.pdf octreotide.pdf H01CB02 R
OCTREOTIDE TEVA 30MG INJ PLQ SUS PRO 1+1X2ML ISP
0227029 56/ 469/17-C octreotide.pdf octreotide.pdf H01CB02 R
OCTREOTIDE TEVA 20MG INJ PLQ SUS PRO 1+1X2ML ISP
0227028 56/ 468/17-C octreotide.pdf octreotide.pdf H01CB02 R
OCTREOTIDE TEVA 10MG INJ PLQ SUS PRO 1+1X2ML ISP
0227027 56/ 467/17-C octreotide.pdf octreotide.pdf H01CB02 R
OCTREOTIDE TEVA B. V. 20MG INJ PLQ SUS PRO 1+1X2ML ISP
0227034 56/ 474/17-C octreotide.pdf octreotide.pdf H01CB02 R
OCTREOTIDE TEVA B. V. 10MG INJ PLQ SUS PRO 3+3X2ML ISP
0243401 56/ 473/17-C octreotide.pdf octreotide.pdf H01CB02 R
OCTREOTIDE TEVA B. V. 20MG INJ PLQ SUS PRO 3+3X2ML ISP
0243402 56/ 474/17-C octreotide.pdf octreotide.pdf H01CB02 R
OCTREOTIDE TEVA B. V. 10MG INJ PLQ SUS PRO 1+1X2ML ISP
0227033 56/ 473/17-C octreotide.pdf octreotide.pdf H01CB02 R
OCTREOTIDE TEVA B. V. 30MG INJ PLQ SUS PRO 3+3X2ML ISP
0243403 56/ 475/17-C octreotide.pdf octreotide.pdf H01CB02 R
OCTREOTIDE TEVA B. V. 30MG INJ PLQ SUS PRO 1+1X2ML ISP
0227035 56/ 475/17-C octreotide.pdf octreotide.pdf H01CB02 R
OCTREOTIDE TEVA CR 10MG INJ PLQ SUS PRO 3+3X2ML ISP
0242716 56/ 470/17-C octreotide.pdf octreotide.pdf H01CB02 R
OCTREOTIDE TEVA CR 30MG INJ PLQ SUS PRO 1+1X2ML ISP
0227032 56/ 472/17-C octreotide.pdf octreotide.pdf H01CB02 R
OCTREOTIDE TEVA CR 30MG INJ PLQ SUS PRO 3+3X2ML ISP
0242714 56/ 472/17-C octreotide.pdf octreotide.pdf H01CB02 R
OCTREOTIDE TEVA CR 10MG INJ PLQ SUS PRO 1+1X2ML ISP
0227030 56/ 470/17-C octreotide.pdf octreotide.pdf H01CB02 R
OCTREOTIDE TEVA CR 20MG INJ PLQ SUS PRO 3+3X2ML ISP
0272715 56/ 471/17-C octreotide.pdf octreotide.pdf H01CB02 R
OCTREOTIDE TEVA CR 20MG INJ PLQ SUS PRO 1+1X2ML ISP
0227031 56/ 471/17-C octreotide.pdf octreotide.pdf H01CB02 R
OFOST 10IU/ML INJ/INF SOL 100X1ML
0221540 56/ 091/17-C ofost.pdf ofost.pdf H01BB02 R

‹‹ ‹ 1 2 3 4 5 6 7 8 9 10 › ››

Medicinal products reimbursed from health insurance are blue-tinged and marked with sign.

Medicinal products on the Czech market in line with periodical report from wholesalers in last 3 months (with monthly distance) are sign and are typed in bold

Last update of registration information: 30. November 2021 at 00:09
Last update of price and payment data: 30. October 2021 at 01:12